Tailored Exercise to Reduce Aromatase Inhibitor Associated Musculoskeletal Symptoms

Mahidol University206 enrolled

Overview

A randomized controlled study evaluating effect of tailored exercise compared to routine practice as a preventive measure of aromatase inhibitor associated musculoskeletal related symptoms in early breast cancer patients

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

SINGLE

Enrollment

206

Conditions

Patients With Early Breast Cancer Who Initiating Adjuvant Aromatase Inhibitor

Interventions

tailored exerciseBEHAVIORAL

tailored suitable exercise to individuals recommended for the aim of aerobic exercise at 150 minutes per week and strengthening exercise twice a week

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * breast cancer patients with starting adjuvant aromatase inhibitor within 4 weeks * able to read and write Exclusion Criteria: * chronic arthritis * history of heart failure or acute coronary syndrome within 6 months * individuals who exercises regularly more than 150 minutes/week

Locations (1)

Faculty of Medicine Siriraj Hospital, Mahidol University

Bangkok, Thailand

RECRUITING

Outcomes

Primary Outcomes

Aromatase inhibitor associated musculoskeletal symptoms (AIMSS)

occurrence of AIMSS

Time frame: 12 months

Secondary Outcomes

worsening pain

reduce numerical scale of pain more than 2 points

Time frame: 12 months

body weight

body weight change

Time frame: 12 months

quality of life FACT-ES

FACT-ES score

Time frame: 12 months

Central Contacts

Suthinee Ithimakin, M.D

CONTACT

+66898127440 aesi105@yahoo.co.th

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.